Work

Genotype-directed phase II study of irinotecan dosing in metastatic colorectal cancer (mCRC) patients receiving FOLFIRI + bevacizumab: The GENIC study.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.tps3621

Authors: Grant Richard Williams, Federico Innocenti, William Allen Wood, Jai Narendra Patel, Gary Bradley Sherrill, Bert H. O'Neil, Jeremiah C. Boles, Ethan M. Basch, Hanna Kelly Sanoff

Institutions: University of North Carolina at Chapel Hill, Levine Cancer Institute, Moses H Cone Memorial Hospital, Indiana University Health, Indiana University Hospital, Rex Hospital

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2920844543

Cites:

Cited by: 2

Related to: 10